EP2090657A3

Anti-IL-12 antibodies, compositions, methods and uses

Abstract

The present invention relates to at least one novel anti-IL-12 antibodies, including isolated nucleic acids that encode at least one anti-IL-12 antibody, IL-12, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.

Term

Term ended

Projected expiry passed 7 August 2021, 5.1 years ago.

Every citation, both ways

Citations
Document	Relation	Office	Category	Cited during	Relevant claims
WO0056772A1	Cites	World Intellectual Property Organization (WIPO)	XP	Search report	5,6,11-13
EP0640689A2	Cites	European Patent Office (EPO)	A	Search report	1-14
WO9633735A1	Cites	World Intellectual Property Organization (WIPO)	A	Search report	1-14
WO9715327A1	Cites	World Intellectual Property Organization (WIPO)	I	Search report	1-14
WO9937682A2	Cites	World Intellectual Property Organization (WIPO)	I	Search report	1-14
YAWALKAR NIKHIL ET AL: "Expression of interleukin-12 is increased in psoriatic skin.", JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 111, no. 6, December 1998 (1998-12-01), pages 1053 - 1057, XP008005771, ISSN: 0022-202X	Non-patent	–	–	Search report	–
PADLAN ET AL: "Anatomy of the antibody molecule", MOLECULAR IMMUNOLOGY, PERGAMON, GB, vol. 31, no. 3, 1 February 1994 (1994-02-01), pages 169 - 217, XP023681629, ISSN: 0161-5890, [retrieved on 19940201], DOI: 10.1016/0161-5890(94)90001-9	Non-patent	–	–	Search report	–

185 members in 44 offices

This recordMember, by publication datePriority claim34 more offices are in the list below

Priority claims7

Priority claims
Document	Office	Kind	Date
223358P	United States of America	–	2000-08-07
22335800	United States of America	P	2000-08-07
236827P	United States of America	–	2000-09-29
23682700	United States of America	P	2000-09-29
920262	United States of America	–	2001-08-01
92026201	United States of America	A	2001-08-01
01959598	European Patent Office (EPO)	A	2001-08-07

Members185

Family members, oldest first
Document	Office	Kind
CA2418961A1	Canada	A1	2002-02-14
WO0212500A2	World Intellectual Property Organization (WIPO)	A2	2002-02-14
AU8113701A	Australia	A	2002-02-18
WO0212500A3	World Intellectual Property Organization (WIPO)	A3	2003-01-03
NO20030614D0	Norway	D0	2003-02-07
NO20030614L	Norway	L	2003-04-02
KR20030034133A	Republic of Korea	A	2003-05-01
EP1309692A2	European Patent Office (EPO)	A2	2003-05-14
US2003124123A1	United States of America	A1	2003-07-03
AR030134A1	Argentina	A1	2003-08-13
EA200300137A1	Eurasian Patent Organization (EAPO)	A1	2003-08-28
IL154325A0	Israel	A0	2003-09-17
MXPA03001229A	Mexico	A	2003-10-15
MXPA03001229A	Mexico	A	2003-10-15
HU0302378A2	Hungary	A2	2003-10-28
HUP0302378A2	Hungary	A2	2003-10-28
CN1468309A	China	A	2004-01-14
BR0113109A	Brazil	A	2004-02-03
BR0113109A	Brazil	A	2004-02-03
ZA200301867B	South Africa	B	2004-08-25
PL360258A1	Poland	A1	2004-09-06
JP2004527212A	Japan	A	2004-09-09
NZ524145A	New Zealand	A	2004-11-26
US2005002937A1	United States of America	A1	2005-01-06
US2005112127A1	United States of America	A1	2005-05-26
US6902734B2	United States of America	B2	2005-06-07
US2005196838A1	United States of America	A1	2005-09-08
US2005214293A1	United States of America	A1	2005-09-29
HRP20030087A2	Croatia	A2	2005-10-31
EA006673B1	Eurasian Patent Organization (EAPO)	B1	2006-02-24
UY29291A1	Uruguay	A1	2006-03-31
YU9303A	Yugoslavia, later Serbia and Montenegro (until 2006)	A	2006-05-25
US7063964B2	United States of America	B2	2006-06-20
AU2005319278A1	Australia	A1	2006-06-29
CA2591813A1	Canada	A1	2006-06-29
WO2006069036A2	World Intellectual Property Organization (WIPO)	A2	2006-06-29
PE20061115A1	Peru	A1	2006-10-12
TW200636065A	Taiwan Province of China	A	2006-10-16
US7166285B2	United States of America	B2	2007-01-23
NZ535865A	New Zealand	A	2007-01-26
AR051805A1	Argentina	A1	2007-02-07
AU2001281137B2	Australia	B2	2007-03-15
WO2006069036A3	World Intellectual Property Organization (WIPO)	A3	2007-07-26
NO20073778L	Norway	L	2007-09-18
EP1836294A2	European Patent Office (EPO)	A2	2007-09-26
KR20070094927A	Republic of Korea	A	2007-09-27
US7279157B2	United States of America	B2	2007-10-09
MY133377A	Malaysia	A	2007-11-30
UA81100C2	Ukraine	C2	2007-12-10
EA200701363A1	Eurasian Patent Organization (EAPO)	A1	2007-12-28
CN101120087A	China	A	2008-02-06
US2008090290A1	United States of America	A1	2008-04-17
KR100823576B1	Republic of Korea	B1	2008-04-21
NI200700155A	Nicaragua	A	2008-05-07
JP2008523842A	Japan	A	2008-07-10
BRPI0515858A	Brazil	A	2008-08-12
IL183939A0	Israel	A0	2008-12-29
CR9265A	Costa Rica	A	2009-01-16
ZA200706036B	South Africa	B	2009-01-28
EP1309692B1	European Patent Office (EPO)	B1	2009-05-13
AT431412T	Austria	T	2009-05-15
ATE431412T1	Austria	T1	2009-05-15
PT1309692E	Portugal	E	2009-05-21
DK1309692T3	Denmark	T3	2009-06-15
EP1836294A4	European Patent Office (EPO)	A4	2009-06-17
DE60138711D1	Germany	D1	2009-06-25
NL300390I1	Netherlands (Kingdom of the)	I1	2009-07-01
US7560247B2	United States of America	B2	2009-07-14
CL2009000575A1	Chile	A1	2009-07-17
ES2323760T3	Spain	T3	2009-07-24
US2009202549A1	United States of America	A1	2009-08-13
EP2090657A2	European Patent Office (EPO)	A2	2009-08-19
SI1309692T1	Slovenia	T1	2009-08-31
LU91584I2	Luxembourg	I2	2009-09-10
DE122009000025I1	Germany	I1	2009-09-17
FR09C0021I1	France	I1	2009-09-25
CN101550190A	China	A	2009-10-07
CA2418961C	Canada	C	2009-11-03
US2009274707A1	United States of America	A1	2009-11-05
SG158150A1	Singapore	A1	2010-01-29
NL300390I2	Netherlands (Kingdom of the)	I2	2010-03-01
RS50477B	Serbia	B	2010-03-02
NZ555658A	New Zealand	A	2010-04-30
FR09C0021I2	France	I2	2010-06-11
HK1135991A	Hong Kong, China	A	2010-06-18
HK1135991A1	Hong Kong, China	A1	2010-06-18
TWI329672B	Taiwan Province of China	B	2010-09-01
IL154325A	Israel	A	2010-12-30
MEP44408A	Montenegro	A	2011-02-10
US7887807B2	United States of America	B2	2011-02-15
EP2305817A2	European Patent Office (EPO)	A2	2011-04-06
US2011082190A1	United States of America	A1	2011-04-07
ME00326B	Montenegro	B	2011-05-10
PY0539343A	Paraguay	A	2011-06-01
NZ583153A	New Zealand	A	2011-06-30
JP4731094B2	Japan	B2	2011-07-20
NO330903B1	Norway	B1	2011-08-15
JP2011173884A	Japan	A	2011-09-08
NO2011023I2	Norway	I2	2011-10-04
NO2011023I1	Norway	I1	2011-10-17

Showing 100 of 185

90 legal events, as 16 offices reported them to INPADOC

Over the term

Point at a mark for the event

Events

Legal events, newest first
	Event	Code	Office
2023-07-05	Opt-out of the competence of the unified patent court (upc) registeredP01	P01	EP
2022-06-01	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2022-01-28	Announcement of lapse in spainLapsedFD2A	FD2A	ES
2021-11-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2021-11-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2021-10-29	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2021-10-12	Ep patent expiredExpiredMAE	MAE	FI
2021-09-30	Patent expired because of reaching the maximum lifetime of a patentExpiredMK	MK	BE
2021-09-29	Patent expiredExpiredMK9A	MK9A	IE
2021-09-28	Ep patent has lapsedLapsedEUG	EUG	SE
2021-09-15	ExpiryMK07	MK07	AT
2021-09-01	Patent expired after termination of 20 yearsExpiredPE20	PE20	GB
2021-08-25	Lapsed patentsLapsedMM9A	MM9A	LT
2021-08-16	Patent ceasedCeasedPL	PL	CH
2021-08-11	Patent expired because of reaching the maximum lifetime of a patentExpiredMK	MK	NL
2021-08-09	Ep patent expiredExpiredEUP	EUP	DK
2021-08-07	Expiry of rightR071	R071	DE
2020-11-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2020-11-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2020-11-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2020-11-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2020-11-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2020-10-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2020-10-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2020-10-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2020-10-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2020-10-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2020-10-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2020-10-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2020-10-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2020-10-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2020-10-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2020-10-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2020-10-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2020-10-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2020-09-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2019-10-15	Publication of translation of european patent specificationUEP	UEP	AT
2018-07-12	Fee paymentPLFP	PLFP	FR
2018-02-07	No opposition filedOpposition26N	26N	EP
2018-01-05	No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE	PLBE	EP
2018-01-05	Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA	STAA	EP
2017-12-04	No opposition filed against granted patent, or epo opposition proceedings concluded without decisionGrantedR097	R097	DE
2017-11-02	Ep patent validated in greeceEP	EP	GR
2017-07-14	Definitive protectionFG2A	FG2A	ES
2017-07-14	Fee paymentPLFP	PLFP	FR
2017-06-06	Ep patent with danish claimsT3	T3	DK
2017-05-03	Translation for ep filed (entry of ep into country)FP	FP	NL
2017-05-03	Translation is availableAVAILABILITY OF NATIONAL TRANSLATIONSC4A	SC4A	PT
2017-04-13	Dpma publication of mentioned ep patent grantGrantedR096	R096	DE
2017-03-28	Translation of granted ep patentGrantedTRGR	TRGR	SE
2017-03-22	European patents granted designating irelandGrantedFG4D	FG4D	IE
2017-03-15	European patent takes effect as a national patent in ch/liEP	EP	CH
2017-03-15	New agentNV	NV	CH
2017-03-15	Reference to at number (ep patent validated in austria)REF	REF	AT
2017-03-01	Divisional application: reference to earlier applicationAC	AC	EP
2017-03-01	Designated contracting statesAK	AK	EP
2017-03-01	Request for extension of the european patentAX	AX	EP
2017-03-01	European patent grantedGrantedFG4D	FG4D	GB
2017-01-27	(expected) grantORIGINAL CODE: 0009210GRAA	GRAA	EP
2017-01-24	Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS	GRAS	EP
2016-11-23	Intention to grant announcedINTG	INTG	EP
2016-11-23	Information on inventor provided before grant (corrected)RIN1	RIN1	EP
2016-11-23	Information on inventor provided before grant (corrected)RIN1	RIN1	EP
2016-11-23	Information on inventor provided before grant (corrected)RIN1	RIN1	EP
2016-11-23	Information on inventor provided before grant (corrected)RIN1	RIN1	EP
2016-11-23	Information on inventor provided before grant (corrected)RIN1	RIN1	EP
2016-10-24	Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP	GRAP	EP
2013-11-27	First examination report despatched17Q	17Q	EP
2012-08-08	Request for examination filed17P	17P	EP
2011-12-28	Designated contracting statesAK	AK	EP
2011-12-28	Request for extension of the european patentAX	AX	EP
2011-12-28	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2011-12-28	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2011-12-28	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2011-12-28	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2011-12-28	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2011-12-28	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2011-12-28	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2011-12-28	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2011-12-28	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2011-11-25	Search report despatchedORIGINAL CODE: 0009013PUAL	PUAL	EP
2011-11-02	Party data changed (applicant data changed or rights of an application transferred)RAP1	RAP1	EP
2009-10-14	Information on inventor provided before grant (corrected)RIN1	RIN1	EP
2009-10-14	Information on inventor provided before grant (corrected)RIN1	RIN1	EP
2009-10-14	Information on inventor provided before grant (corrected)RIN1	RIN1	EP
2009-10-14	Information on inventor provided before grant (corrected)RIN1	RIN1	EP
2009-10-14	Information on inventor provided before grant (corrected)RIN1	RIN1	EP
2009-08-19	Divisional application: reference to earlier applicationAC	AC	EP
2009-08-19	Designated contracting statesAK	AK	EP
2009-07-17	Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI	PUAI	EP

Anti-IL-12 antibodies, compositions, methods and uses

Abstract

Term

Priority claims7

Members185

Over the term

Events

Numbers

Titles3

Classification

Designated states26